Sanofi-A Ventis Deutschland Gmbh

Sanofi

Gerrit Hauck

Werner Mueller

Bernd Kuhn

Verena Siefke-Henzler

Annika Hagendorf

Isabell Schoettle

Katrin Tertsch

A liquid composition comprising a GLP-1 agonist or/and a pharmacologically tolerable salt thereof, an insulin or/and a pharmacologically tolerable salt thereof, and, optionally, at least one pharmaceutically acceptable excipient, wherein the composition comprises methionine, as add-on therapy with metformin where appropriate.

Pharmaceutical composition comprising a GLP-1 agonist, an insulin and methionine

The invention relates to solid pharmaceutical compositions comprising (Z)-2-cyano-3-hydroxy-but-2-enoic acid-(4'-trifluoromethylphenyl)-amide, as well as a process for the preparation of the same, methods of using such compositions to treat subjects suffering from autoimmune diseases in particular systemic lupus erythematosus or chronic graft-versus-host disease, multiple sclerosis or rheumatoid arthritis.

(Z)-2-cyano-3-hydroxy-but-2-enoic acid-(4'-trifluormethylphenyl)-amide tablet formulations with improved stability

A cannula assembly () comprising a hub () and a cannula () mounted in the hub (). The cannula defines an inner space (). The cannula comprises a distal end () and a proximal end (). A first medicament () is provided in the inner space of the cannula. In one arrangement, the hub of the cannula assembly is configured to be coupled to an injection device (). The cannula assembly may be removably or permanently coupled to the injection device containing a second medicament ().

Cannula assembly for co-delivery of medicaments

Growing community of inventors

Frankfurt am Main, Germany

Gerrit Hauck